Equity
€284,698 ▼ 3.1%
Endomax paid out €134,900 in dividends. That is 107% of the 2025 profit.
Endomax
Lifetime
6 annual accounts with figures on one time axispeak €130,667 (2020)
€103,877▼ 14.2%
peak €125,682 (2025)
€125,682▲ 96.1%
peak €293,916 (2024)
€284,698▼ 3.1%
€435,969▲ 12.5%
peak 0 FTE (2025)
0 FTE
Board1 name since 2019
1 director
Documentsfilings and deeds
15-06-202646 days before the deadline
2025abbreviated format
Gross margin from €121,088 to €103,877Result from €64,082 to €125,682Dividend €134,900Cash from €31,951 to €109,141
Key points
from the 2025 annual accountsResult
€125,682 ▲ 96.1%
The result rose in 2025 from €64,082 to €125,682.
Turnover
≈ €260,000 estimated
The accounts state no turnover.
Securities
€229,083
Mortgage mandates, new in 2025. 80.5% of equity · not in the 2024 accounts.
Filings
6 annual accounts 2 late
The 2021 accounts came latest: 17 days after the end of the period.
Starting capital
€1,000 100 shares
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,780 companies had the same profile as Endomax has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,780 companies, not a prediction for Endomax. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0736598994
Incorporation
Founding capital of €1,000, 100 shares · Founder: · Appointment: (director) · published on 23-10-2019 · Gazette deed
First establishment
Pastoor Moonslaan 58, Edegem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Endomax Edegem | €720,667 | €103,877 | 39.5% | 0 |
| Ra-Mond Roeselare | €738,930 | €129,114 | 22.2% | 0 |
| LILAN Middelkerke | €483,158 | €85,072 | 69.0% | 0 |
| JHDental Sint-Pieters-Leeuw | €513,515 | €87,453 | 8.3% | 0.5 |
| D212 Anderlecht | €549,270 | €126,732 | 45.5% | 0.3 |
| Muelitas Wuustwezel | €836,838 | €103,649 | 7.0% | - |
| Dr. Seyde Ismailova Antwerp | €644,731 | €83,782 | 29.6% | - |
These companies have the same main activity as Endomax: dental practice (NACE 86230). They are comparable in size and age: total assets between €483,000 and €837,000, founded between 2013 and 2020.
Official details
Source: KBO- Status
- Active since 21-10-2019Normal situation
- Activity
- Dental practiceNACE 86230
- Establishment unit
- 2.294.895.8782650 Edegem, since 21-10-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 02-12-2024
Annual accounts 2025
- €720,667▲ 5.8%
- Filing
- Filed on 15-06-2026, 46 days before the end of the filing period
Insights on Endomax
Endomax files the abbreviated format. That format states no turnover. The gross margin fell from €130,667 in 2020 to €103,877 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Endomax
- What is the company number of Endomax?
- The company number of Endomax is 0736.598.994. The VAT number is the same number with BE in front: BE 0736.598.994.
- Where is Endomax based?
- The registered office is at Pastoor Moonslaan 58, 2650 Edegem.Company details
- What does Endomax do?
- According to the KBO register, the main activity is dental practice (NACE 86230).
- What is the legal form of Endomax?
- Endomax is a private limited company (BV).
- When was Endomax founded?
- Endomax was founded on 21-10-2019.
- Is Endomax still active?
- Yes, Endomax is an active enterprise in the KBO register.
- What is the turnover of Endomax?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €103,877 and 31 comparable companies (NACE 86230). It probably lies between €180,000 and €300,000.Financials
- Is Endomax profitable?
- In financial year 2025, Endomax made a profit of €125,682.
- Where can I find the annual accounts of Endomax?
- Endomax filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Endomax due?
- Endomax must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.